Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome

Annals of Clinical Biochemistry

Volumn 38, Issue 1, 2001, Pages 28-36

  Benn, P A ^a   Collins, R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ARTICLE; DATA ANALYSIS; DEVICE; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FETUS; HUMAN; MATERNAL SERUM; MULTIVARIATE ANALYSIS; PREDICTION; PRENATAL SCREENING; PRIORITY JOURNAL; REPRODUCIBILITY; RISK FACTOR; UNITED STATES;

ANALYSIS OF VARIANCE; DATA INTERPRETATION, STATISTICAL; DOWN SYNDROME; FEMALE; HUMANS; MODELS, STATISTICAL; NORMAL DISTRIBUTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0035175413     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011900254     Document Type: Article

References (25)

1. Maternal serum screening for Down's syndrome in early pregnancy
2. Maternal serum screening for Down syndrome in the United States: A 1995 survey
3. Prenatal screening for Down syndrome
4. The mathematical basis of multivariate risk screening: With special reference to screening for Down syndrome associated pregnancy
5. Age-specific detection and false-positive rates: An aid to counseling in Down syndrome risk screening
6. Prenatal screening for Down's syndrome with use of maternal serum markers
7. Antenatal maternal serum screening for Down's syndrome: Results of a demonstration project
8. Maternal serum screening for Down's syndrome: The effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight
9. Biochemical screening for Down syndrome
10. Down syndrome and neural tube defect screening: The value of using gestational age by ultrasonography
11. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple marker testing as screen-positive for Down's syndrome
12. A multi-rule Shewhart chart for quality control in clinical chemistry
13. Practical problems in Down syndrome screening: What should we do about gestation dating? What is the effect of assay imprecision on risk factors?
14. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level
15. Economic evaluation of prenatal screening for Down syndrome in the USA
16. The United Kingdom external quality assessment scheme for screening for Down syndrome
17. Screening for fetal trisomy 21 in the first trimester: Maternal serum free β-hCG and fetal nuchal translucency thickness
18. Screening of maternal serum for fetal Down's syndrome in the first trimester
19. Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results
20. Adjusting the risk for trisomy 21 on the basis of second trimester ultrasonography
21. Coping with serum screening for Down syndrome when the result is given as a numeric value